![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Preinitiation |
Unique ID issued by UMIN | UMIN000048111 |
Receipt No. | R000054833 |
Scientific Title | Megaprosthetic reconstruction of distal femur with short residual proximal femur following resection of bone tumor: a systematic review |
Date of disclosure of the study information | 2022/06/20 |
Last modified on | 2022/06/20 |
Basic information | |||
Public title | Megaprosthetic reconstruction of distal femur with short residual proximal femur following resection of bone tumor: a systematic review | ||
Acronym | Megaprosthetic reconstruction of distal femur with short residual proximal femur following resection of bone tumor: a systematic review | ||
Scientific Title | Megaprosthetic reconstruction of distal femur with short residual proximal femur following resection of bone tumor: a systematic review | ||
Scientific Title:Acronym | Megaprosthetic reconstruction of distal femur with short residual proximal femur following resection of bone tumor: a systematic review | ||
Region |
|
Condition | ||
Condition | bone tumor | |
Classification by specialty |
|
|
Classification by malignancy | Malignancy | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | To investigate the risk of postoperative function and complications in patients with short residual proximal femur after resection of a distal femoral bone tumor, we performed a systematic review of studies reporting functional results and complications in patients with short residual proximal femur after reconstruction of a distal femoral bone tumor with custom-made megaprosthesis, APC and CPS implant. |
Basic objectives2 | Safety,Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | mechanical survival where the endpoint was set to implant removal for any reason |
Key secondary outcomes |
Base | |
Study type | Others,meta-analysis etc |
Study design | |
Basic design | |
Randomization | |
Randomization unit | |
Blinding | |
Control | |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | |
No. of arms | |
Purpose of intervention | |
Type of intervention | |
Interventions/Control_1 | |
Interventions/Control_2 | |
Interventions/Control_3 | |
Interventions/Control_4 | |
Interventions/Control_5 | |
Interventions/Control_6 | |
Interventions/Control_7 | |
Interventions/Control_8 | |
Interventions/Control_9 | |
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | Only studies reporting functional results and complications regarding megaprosthetic reconstruction of distal femur with short residual proximal femur following resection of bone tumor were included. | |||
Key exclusion criteria | (1) Studies in which reconstruction was performed in patients without short residual proximal femurs were excluded. Studies that performed reconstruction in patients with short residual proximal femurs and did not specify both functional results and complications were also excluded. (2) Only English- and Japanese-language literature was included, with no restriction on the year of publication. | |||
Target sample size |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Nara medical university | ||||||
Division name | Department of Orthopaedic Surgery | ||||||
Zip code | 634-8521 | ||||||
Address | 840, Shijo-cho, Kashihara-city Nara 634-8521, Japan | ||||||
TEL | 0744223051 | ||||||
shinji104@mail.goo.ne.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Nara Medical University | ||||||
Division name | Department of Orthopaedic Surgery | ||||||
Zip code | 634-8521 | ||||||
Address | 840, Shijo-cho, Kashihara-city Nara 634-8521, Japan | ||||||
TEL | 0744223051 | ||||||
Homepage URL | |||||||
shinji104@mail.goo.ne.jp |
Sponsor | |
Institute | Nara medical university |
Institute | |
Department |
Funding Source | |
Organization | Nara medical university |
Organization | |
Division | |
Category of Funding Organization | Local Government |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Nara Medical University |
Address | 840, Shijo-cho, Kashihara-city, Nara 634-8521, Japan |
Tel | 0744223051 |
shinji104@mail.goo.ne.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Preinitiation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information | Data collection and presentation
Two authors (ST and TM) independently selected the studies and extracted the data. In case of any disagreement, agreement was reached between the two or the third author was consulted. The following data were collected using the data collection sheet. (1) Basic data: author, year of publication, journal name, type of study, number of patients, age of patients, histology of tumor (2) Surgical indication, method of reconstruction, cement fixation, porous coating, time to full weight bearing, stem length of prosthesis, adjuvant chemotherapy, adjuvant radiotherapy, nonunion, aseptic loosening, implant breakage, fracture, infection, mechanical survival where the endpoint was set to implant removal for any reason, oncological outcome, Musculoskeletal Tumor Society (MSTS) score [19], postoperative follow-up period. Data summary Data extracted from the collected study data are summarized in Table 1 and 2. Table 3 summarized the time to full weight bearing, nonunion, aseptic loosening, implant breakage, fracture, infection, mechanical survival, MSTS score [19], and postoperative follow-up period for each reconstruction method (custom-made megaprosthesis, APC, and CPS implant). Because all the studies included in this review were non-randomized, data pooling (meta-analysis) was not appropriate, and thus, not performed. Assessment of methodological quality Two authors (ST and TM) independently assessed the quality of the included studies. When there was disagreement, agreement was reached between the two authors or by consulting a third author. Articles included in the final analysis were independently assessed according to the Risk of Bias Assessment tool for Non-randomized Studies (RoBANS tool) for assessing the quality of non-randomized studies in meta-studies [20]. |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054833 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |